What is T1D Exchange?
T1D Exchange operates as a specialized nonprofit organization dedicated to accelerating the development of therapies and improving health outcomes for the type 1 diabetes community. By fostering a collaborative ecosystem that integrates patient data, clinical expertise, and research initiatives, the organization serves as a central hub for quality improvement. Their market position is defined by a unique ability to mobilize both patients and healthcare professionals, facilitating large-scale research projects that would otherwise be fragmented. Through custom research services and community-driven engagement, T1D Exchange effectively translates complex medical data into actionable insights that drive systemic improvements in diabetes care.
How much funding has T1D Exchange raised?
T1D Exchange has raised a total of $1.6M across 2 funding rounds:
Debt
$1M
Debt
$624K
Debt (2020): $1M with participation from PPP
Debt (2021): $624K led by PPP
Key Investors in T1D Exchange
PPP
Public-Private Partnership
What's next for T1D Exchange?
With the recent influx of capital, T1D Exchange is well-positioned to scale its research infrastructure and expand its quality improvement initiatives. The organization is expected to prioritize the integration of advanced data analytics to further refine patient-centered care models. By deepening its partnerships with clinical stakeholders and research institutions, T1D Exchange aims to accelerate the pipeline of therapeutic breakthroughs. This strategic phase will likely focus on enhancing the accessibility of its research platform, thereby increasing the velocity of clinical trials and ensuring that the voices of those living with type 1 diabetes remain central to the evolution of medical treatment protocols.
See full T1D Exchange company page
